Investors See Far Out Profits in Psychedelic Medicine
It’s been a long strange trip for Brom Rector to become one of the few venture capitalists investing exclusively in psychedelic medicine. The 31-year-old has been experimenting with drugs like LSD for a decade but he never imagined he could turn that interest into a career.
- 2022 beauty and wellness trends report (US survey reveals consumers are more focused on wellness than ever before, what wellness services are leading in the industry rebound, and more
- Arise raises over $4m to build inclusive eating disorder treatment and mental health platform